Maravai LifeSciences Holdings, Inc.
NASDAQ:MRVI
9.16 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 288.945 | 883.001 | 799.24 | 284.098 | 143.14 | 123.833 |
| Cost of Revenue
| 151.343 | 168.957 | 140.561 | 79.649 | 66.849 | 60.765 |
| Gross Profit
| 137.602 | 714.044 | 658.679 | 204.449 | 76.291 | 63.068 |
| Gross Profit Ratio
| 0.476 | 0.809 | 0.824 | 0.72 | 0.533 | 0.509 |
| Reseach & Development Expenses
| 17.28 | 18.369 | 15.219 | 9.304 | 3.627 | 4.499 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 41.194 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 124.519 | 129.259 | 100.064 | 94.245 | 48.354 | 41.194 |
| Other Expenses
| -1.337 | -0.358 | 0.279 | -7.466 | 0.118 | 0.087 |
| Operating Expenses
| 141.799 | 147.628 | 115.283 | 103.549 | 51.981 | 45.693 |
| Operating Income
| -4.197 | 574.216 | 554.645 | 67.597 | 23.988 | 16.436 |
| Operating Income Ratio
| -0.015 | 0.65 | 0.694 | 0.238 | 0.168 | 0.133 |
| Total Other Income Expenses Net
| 621.933 | -22.744 | -23.88 | 14.099 | -29.841 | -6.474 |
| Income Before Tax
| 617.736 | 551.472 | 530.765 | 81.696 | -5.853 | -16.498 |
| Income Before Tax Ratio
| 2.138 | 0.625 | 0.664 | 0.288 | -0.041 | -0.133 |
| Income Tax Expense
| 756.111 | 60.809 | 61.515 | 2.88 | -0.652 | 0.417 |
| Net Income
| -119.029 | 490.663 | 469.25 | 76.888 | -5.201 | -17.731 |
| Net Income Ratio
| -0.412 | 0.556 | 0.587 | 0.271 | -0.036 | -0.143 |
| EPS
| -0.9 | 3.73 | 4.09 | 0.8 | -0.054 | -0.2 |
| EPS Diluted
| -0.9 | 1.92 | 1.82 | 0.7 | -0.054 | -0.2 |
| EBITDA
| 44.584 | 568.396 | 543.675 | 93.434 | 48.512 | 39.809 |
| EBITDA Ratio
| 0.154 | 0.644 | 0.68 | 0.329 | 0.339 | 0.321 |